87784846 - ONESOURCE

Information

• Trademark
• 87784846

• Source

• Serial Number

  87784846

• Registration Number

  6688750

• International Classifications

  • 35 - Advertising
  • 37 - Building construction
  • 41 - Education
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  February 05, 2018
  7 years ago

• Registration Date

  April 05, 2022
  3 years ago

• Transaction Date

  July 25, 2024
  8 months ago

• Status Date

  April 05, 2022
  3 years ago

• Published for Opposition Date

  August 11, 2020
  4 years ago

• Location Date

  April 05, 2022
  3 years ago

• First Use Anywhere Date

  October 01, 2014
  10 years ago

• First Use In Commerce Date

  October 01, 2014
  10 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  WATSON, BRIDGET ANNE

• Attorney Docket Number

  802761002270

  Attorney Name

  Carrie Webb Olson

  Law Office Assigned Location Code

  O10

• Owners

  • PerkinElmer Health Sciences, Inc.

Case File Statements

• GS0411: Training services, namely, business training advisory and consultancy services relating to the use, handling, optimization, calibration, and maintenance of laboratory equipment and related software; educational services, namely, conducting technical discussion meetings and technical training seminars on topics of business, administration operation, regulatory and standards compliance, and management of scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories, experimental testing and analysis, data management, and quality assurance
• GS0371: Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of laboratory instruments for scientific, pharmaceutical, and medical research, analysis, and diagnostic use; Installation, maintenance, optimization in the nature of repair consultation, repair, and refurbishment of computer hardware for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Laboratory equipment installation for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories
• GS0351: Relocation services for businesses, namely, laboratories; relocation services for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories, namely, inventory recordation and equipment labeling in the nature of inventory management and transportation logistics, namely, arranging the transportation of goods for others; services in the nature of arranging transportation of specimens, chemicals, and samples for others; business management consulting services, namely, laboratory application efficiency and method consulting and design for scientific research and medical analytical and diagnostic laboratories in the nature of identification of customer objectives and goals and providing strategic recommendations; business management consulting services, namely, research, analysis, and reporting in the field of workflow, productivity analysis, and personnel management in scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories for business purposes; consulting services, namely, providing business information and business management advice to others for maintaining, optimizing, and extending the lifecycle and productivity of analytical and diagnostic laboratory equipment; business management consulting services in the field of purchases, namely, assisting laboratories with the purchase of scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments; business management consulting services in the field of science and technology, namely, assisting laboratories with identifying scientific, pharmaceutical, and medical research, analytical, and diagnostic instruments for purchase; employment staffing services, namely, filling the temporary staffing needs of scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories; benchmarking services for scientific, medical, and pharmaceutical research and diagnostic laboratories and equipment, namely, analyzing and providing business strategic planning feedback regarding performance efficiency, usage and throughput, regulatory compliance, and quality standards; information technology support services in the nature of asset management and risk mitigation, namely, reporting on service histories, utilization of the medical assets, end of product life information and replacement costs all related to medical diagnostic, clinical and biomedical equipment
• GS0441: Laboratory Medical services in the nature of medical analysis and diagnosis, excluding analysis and diagnosis at the point of patient care; genetic analysis and reporting services for medical purposes; nucleic acid sequencing and analysis services for medical purposes; genome sequencing and analysis services for medical purposes; DNA screening for medical purposes; consultation in the field of medicine, health and pharmaceuticals, excluding consultation at the point of patient care and in pharmacies; DNA and polynucleic acid testing services being medical diagnostic services; conducting medical tests to diagnose disease
• GS0421: Data services, namely, data integrity governance, data management, data reporting, data monitoring, data translation, data transformation, data storage, data analytics, and data integration for data generated in scientific, pharmaceutical, and medical research, analytical and diagnostic laboratories; computer support services for laboratories, namely, providing information technology technical support performed by science-knowledgeable professionals, and electronic monitoring of data from laboratory instruments for quality control purposes; information technology services in the nature of planning, designing, implementing, deploying, installing, customizing, integrating, managing, migrating, testing, validating, and supporting of scientific and laboratory informatics data systems, applications, processes, and technologies; analytics services in the nature of implementation and management of web portals, mobile applications, interactive dashboards, connected instrument utilization, RFID powered asset location, predictive maintenance, and data-driven prescriptive recommendations in the fields of scientific, pharmaceutical, and medical research and diagnostic laboratories; remote technical and diagnostic support in the nature of monitoring technological functions of laboratory instruments for scientific, medical, and pharmaceutical research and diagnostics use; remote technical and diagnostic support in the nature of monitoring technological functions of computer hardware for scientific, research, medical, and diagnostics use; technology testing, inspection, evaluation, verification, analysis and development of laboratory equipment and protocols to verify compliance with regulatory, quality, quantity, consistency, performance, ethical or safety standards; computational chemistry services in the nature of biological research for identification, design, optimization, and study of biologics; research in the fields of science, technology, medicine and health, namely, tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization, for others for use in life science research and biotechnology research; consultation services in the field of science and technology, namely, consultation in the field of cell and tissue culture maintenance and harvest, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, and scientific efficiencies and productivity, for use in life science research and biotechnology research; medical laboratory, pharmaceutical research and laboratory diagnostic services in the field of DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, and molecular compound characterization for others for use in life science research and biotechnology research; laboratory support services, namely, cell and tissue culture maintenance and harvest, preparation of cell and tissue media, DNA and RNA extraction, protein purification, nucleic sequencing, analysis and synthesis of oligonucleotides and other molecules, analysis of absorption, distribution, metabolism, and excretion of pharmacological and molecular compounds, perform cell-based and enzyme assays, in vitro and in vivo phenotypic analysis, molecular compound characterization, sample preparation and management, consumable laboratory product management, tracking usage, maintenance and management of assets and inventory, implementation of scientific efficiencies and productivity for others for use in life science research and biotechnology research, and daily equipment start-up and shut down; planning and layout design services for laboratories; consulting services in the field of laboratory automation; Installation, maintenance, optimization, repair, and refurbishment of computer software for scientific, medical, and pharmaceutical research, analysis, and diagnostics use; Pre-move testing of laboratory equipment and post-move laboratory equipment testing and calibration for scientific, pharmaceutical, and medical research, analytical, and diagnostic laboratories

Case File Event Statements

• 3/15/2018 - 7 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 2/8/2018 - 7 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 2/13/2018 - 7 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 3/6/2018 - 7 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/15/2018 - 7 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 3/15/2018 - 7 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 8/20/2018 - 6 years ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 8/20/2018 - 6 years ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 8/21/2018 - 6 years ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/11/2018 - 6 years ago

  10 - FINAL REFUSAL WRITTEN Type: CNFR

• 10/11/2018 - 6 years ago

  11 - FINAL REFUSAL E-MAILED Type: GNFR

• 10/11/2018 - 6 years ago

  12 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 10/24/2018 - 6 years ago

  13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/24/2018 - 6 years ago

  14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/24/2018 - 6 years ago

  15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/24/2018 - 6 years ago

  16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/24/2018 - 6 years ago

  17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/7/2018 - 6 years ago

  18 - ASSIGNED TO LIE Type: ALIE

• 11/28/2018 - 6 years ago

  19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/18/2018 - 6 years ago

  20 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/18/2018 - 6 years ago

  21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 12/18/2018 - 6 years ago

  22 - WITHDRAWN FROM ISSUE - SENIOR ATTORNEY REQUEST Type: ISSR

• 1/7/2019 - 6 years ago

  23 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT

• 1/14/2019 - 6 years ago

  24 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 1/14/2019 - 6 years ago

  25 - NON-FINAL ACTION WRITTEN Type: CNRT

• 1/14/2019 - 6 years ago

  26 - NON-FINAL ACTION E-MAILED Type: GNRT

• 1/14/2019 - 6 years ago

  27 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/1/2019 - 6 years ago

  28 - NON-FINAL ACTION WRITTEN Type: CNRT

• 4/1/2019 - 6 years ago

  29 - NON-FINAL ACTION E-MAILED Type: GNRT

• 4/1/2019 - 6 years ago

  30 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/30/2019 - 5 years ago

  31 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/30/2019 - 5 years ago

  32 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/1/2019 - 5 years ago

  33 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/22/2019 - 5 years ago

  34 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/22/2019 - 5 years ago

  35 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/22/2019 - 5 years ago

  36 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/22/2019 - 5 years ago

  37 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/22/2019 - 5 years ago

  38 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 10/24/2019 - 5 years ago

  39 - ASSIGNED TO LIE Type: ALIE

• 10/28/2019 - 5 years ago

  40 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 11/12/2019 - 5 years ago

  41 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR

• 11/20/2019 - 5 years ago

  42 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX

• 11/25/2019 - 5 years ago

  43 - NON-FINAL ACTION WRITTEN Type: CNRT

• 11/25/2019 - 5 years ago

  44 - NON-FINAL ACTION E-MAILED Type: GNRT

• 11/25/2019 - 5 years ago

  45 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 4/21/2020 - 4 years ago

  46 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 4/21/2020 - 4 years ago

  47 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 4/22/2020 - 4 years ago

  48 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/4/2020 - 4 years ago

  49 - ASSIGNED TO EXAMINER Type: DOCK

• 6/8/2020 - 4 years ago

  50 - ASSIGNED TO EXAMINER Type: DOCK

• 6/26/2020 - 4 years ago

  51 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 6/26/2020 - 4 years ago

  52 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 6/26/2020 - 4 years ago

  53 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 6/26/2020 - 4 years ago

  54 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 6/26/2020 - 4 years ago

  55 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 7/8/2020 - 4 years ago

  56 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV

• 7/22/2020 - 4 years ago

  57 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 8/11/2020 - 4 years ago

  58 - PUBLISHED FOR OPPOSITION Type: PUBO

• 8/11/2020 - 4 years ago

  59 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 9/10/2020 - 4 years ago

  60 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF

• 12/8/2020 - 4 years ago

  61 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA

• 1/13/2021 - 4 years ago

  62 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP

• 3/17/2021 - 4 years ago

  63 - ASSIGNED TO PETITION STAFF Type: APET

• 3/22/2021 - 4 years ago

  64 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB

• 4/5/2022 - 3 years ago

  65 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 3/29/2023 - 2 years ago

  66 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN

• 6/21/2023 - a year ago

  67 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 6/21/2023 - a year ago

  68 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 6/21/2023 - a year ago

  69 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 6/21/2023 - a year ago

  70 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 6/21/2023 - a year ago

  71 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/25/2024 - 8 months ago

  74 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 7/25/2024 - 8 months ago

  72 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP

• 7/25/2024 - 8 months ago

  73 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA

• 7/25/2024 - 8 months ago

  75 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS Type: EWAF